Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 17/20 | 0.71 |
| ▸ | CTSL | P07711 | 9/20 | 0.71 |
| ▸ | CTSS | P25774 | 6/20 | 0.71 |
| ▸ | CTSB | P07858 | 1/20 | 0.69 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.62 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.62 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11209608 | 1.00 | CTSK (0.71) | CTSKCTSLCTSSCTSBPSMB1 | |
| SCHEMBL7618462 | 0.93 | CTSK (0.74) | CTSKCTSLCTSSCTSB | |
| SCHEMBL20609249 | 0.92 | CTSK (0.73) | CTSKCTSLCTSSCTSB | |
| SCHEMBL20609250 | 0.92 | CTSK (0.73) | CTSKCTSLCTSSCTSB | |
| SCHEMBL3959352 | 0.90 | CTSK (0.61) | CTSKCTSLCTSSCTSB | |
| SCHEMBL2147583 | 0.90 | CTSK (0.61) | CTSKCTSLCTSSCTSB | |
| SCHEMBL4660369 | 0.90 | CTSK (0.61) | CTSKCTSLCTSSCTSB | |
| SCHEMBL10610800 | 0.89 | CTSK (0.63) | CTSKCTSLCTSSCTSB | |
| SCHEMBL10610794 | 0.89 | CTSK (0.63) | CTSKCTSLCTSSCTSB | |
| SCHEMBL20609256 | 0.88 | CTSK (0.71) | CTSKCTSLCTSSCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115011418-A | Liquid compositions having stabilized protease activity | 南京百斯杰生物工程有限公司 | 2022-09-06 | — | — | CN | disclosed |
| WO-2006001956-A2 | COMPOSITIONS FOR INHIBITING CELL GROWTH AND INDUCING APOPTOSIS IN CANCER CELLS AND METHODS OF USE THEREOF | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2006-01-05 | — | — | WO | disclosed |
| WO-2002101012-A9 | REGULATION OF TRANSGENE EXPRESSION FOLLOWING AAV TRANSDUCTION | CHILDREN S HOSPITAL RES FOUNDA (US) | 2003-12-18 | — | — | WO | disclosed |
| WO-2003064453-A2 | TROJAN INHIBITORS, METHOD FOR THE PRODUCTION AND USE THEREOF | VIROMICS GMBH (DE) | 2003-08-07 | — | — | WO | disclosed |
| WO-2002101012-A2 | REGULATION OF TRANSGENE EXPRESSION FOLLOWING AAV TRANSDUCTION | CHILDREN'S HOSPITAL RESEARCH FOUNDATION (US) | 2002-12-19 | — | — | WO | disclosed |
| CN-1341592-A | Proteinase inhibitor | SMITHKLINE BEECHEM CORP (US) | 2002-03-27 | — | — | CN | disclosed |
| CN-1341590-A | Proteinase inhibitor | SMITHKLINE BEECHEM CORP (US) | 2002-03-27 | — | — | CN | disclosed |
| CN-1341593-A | Proteinase inhibitor | SMITHKLINE BEECHEM CORP (US) | 2002-03-27 | — | — | CN | disclosed |
| EP-1078095-A1 | VIRAL PRODUCTION PROCESS | CANJI, Inc. (US) | 2001-02-28 | — | — | EP | disclosed |
| WO-1999057297-A1 | VIRAL PRODUCTION PROCESS | CANJI, INC. (US) | 1999-11-11 | — | — | WO | disclosed |
| CN-1207095-A | Protease inhibitors | SMITHKLINE BEECHAM CORP (US) | 1999-02-03 | — | — | CN | disclosed |